Navigating the Crossroads: A Compliance Deep Dive into Indiana's Healthcare Regulatory Landscape

2026-06-15

Indiana's healthcare regulatory environment is a dynamic blend of permissive corporate structures and stringent professional practice requirements. For telehealth platforms, national practice groups, and specialized clinics, understanding these nuances is critical for sustainable growth and mitigating risk in the Hoosier State.

The pursuit of healthcare expansion, whether through innovative telehealth models or the strategic growth of brick-and-mortar practices, inevitably leads to navigating diverse state regulatory landscapes. Indiana, often seen as a business-friendly state, presents a unique and sometimes complex set of rules for healthcare providers. For any organization considering entering or expanding within the Hoosier State, a meticulous understanding of its corporate practice of medicine (CPOM) laws, telehealth regulations, controlled substance protocols, and professional licensing requirements is not merely advisable—it is absolutely essential for sustained compliance and operational integrity.

> For more on this topic, see our analysis: [Navigating the Volunteer State: A Deep Dive into Tennessee's Healthcare Regulatory Landscape](/blog/tennessee-healthcare-regulatory-landscape).

Indiana's Stance on the Corporate Practice of Medicine: A Balanced Approach

Unlike many states with strict prohibitions on the corporate practice of medicine (CPOM), Indiana generally adopts a more permissive stance, often characterized as a "no-bar" or "minimal bar" CPOM state. This means that, broadly speaking, non-physician entities, including corporations, are permitted to employ physicians and own medical practices. This less restrictive environment can be attractive to private equity investors, management services organizations (MSOs), and large healthcare systems looking to integrate various services under a single corporate umbrella.

> For more on this topic, see our analysis: [Navigating the Volunteer State: A Deep Dive into Tennessee's Healthcare Regulatory Landscape](/blog/tennessee-healthcare-regulatory-landscape).

However, this permissiveness is not without its critical limitations. While corporations can own practices, the direct practice of medicine and the ultimate clinical decision-making authority must remain with licensed professionals. Indiana still strictly enforces prohibitions against:

Fee-Splitting: Licensed practitioners cannot divide fees for professional services with unlicensed individuals or entities. This is codified, for example, in the Indiana Medical Licensing Board's rules (e.g., 844 IAC 5-2-12). Arrangements must be structured to compensate for legitimate services (e.g., administrative, marketing, facilities) rather than referrals or a percentage of professional fees.
Unlicensed Practice of Medicine: Only licensed physicians (and other licensed professionals within their scope of practice) can provide medical services.
Professional Autonomy: Corporate structures must not interfere with a physician's independent professional judgment regarding patient care.

For Management Services Organizations (MSOs), this means that while they can provide a wide array of administrative, non-clinical services (billing, marketing, HR, IT, real estate, equipment), they must be careful to avoid any perception of controlling clinical decisions or engaging in illegal fee-splitting. MSO agreements in Indiana should clearly delineate the administrative nature of services, ensure fair market value compensation, and explicitly protect the clinical independence of the affiliated professional entity.

Comparison to Neighboring States: While Indiana's CPOM stance is more liberal than that of states like Illinois, which has some specific prohibitions, or Ohio, which explicitly prohibits corporations from practicing medicine, it still shares the fundamental principle that patient care decisions rest solely with licensed providers. Operators moving from highly restrictive CPOM states might find Indiana more accommodating, but vigilance against fee-splitting and maintaining clinical independence remains paramount.

Telehealth in the Hoosier State: A Progressive Pathway

Indiana has been proactive in developing a robust framework for telehealth, recognizing its potential to expand access to care. The state's telehealth laws, primarily found within Indiana Code Title 25 (Professions and Occupations), specifically IC 25-1-9.5, provide a comprehensive definition and regulatory landscape.

Key Aspects of Indiana's Telehealth Regulations:

Definition: Indiana law defines "telehealth" broadly as the use of synchronous or asynchronous telecommunications technology by a healthcare provider to deliver healthcare services within the provider's scope of practice, as long as the provider is at a distant site and the patient is at an originating site.
Payment Parity: Indiana is a payment parity state, meaning that health insurance plans regulated by the state must generally reimburse for telehealth services at the same rate as in-person services, provided the services are medically necessary and appropriately delivered. This significantly boosts the economic viability of telehealth models.
Service Parity: Services delivered via telehealth must meet the same standard of care as if they were provided in-person. This is a critical principle that underscores the responsibility of telehealth providers.
Establishing a Valid Practitioner-Patient Relationship (VPR): Indiana law permits the establishment of a VPR via telehealth. This means an initial in-person visit is not required to initiate telehealth services, provided the provider uses appropriate technology and meets the standard of care to gather necessary medical information.
Eligible Providers: A wide range of licensed healthcare professionals, including physicians, advanced practice registered nurses (APRNs), physician assistants (PAs), dentists, optometrists, psychologists, and others, are authorized to provide services via telehealth within their scope of practice.

Recent Changes and Trends: Indiana has consistently moved towards expanding telehealth access. The state's legislative efforts have focused on ensuring permanent telehealth flexibility post-pandemic, cementing many of the emergency waivers into law. This forward-looking approach positions Indiana as an attractive state for telehealth innovators, but with the expectation of adherence to established standards.

Medical Board Requirements for Telehealth Providers

Compliance with the Indiana Medical Licensing Board (IMLB) (and other professional licensing boards) is non-negotiable for telehealth providers operating in the state. Key requirements include:

Indiana Licensure: Any healthcare provider offering telehealth services to patients located in Indiana must hold a valid, active license issued by the appropriate Indiana professional licensing board, regardless of where the provider is physically located.
Standard of Care: The standard of care for telehealth services is identical to that for in-person services. Providers are expected to conduct a thorough medical evaluation, maintain comprehensive medical records, and ensure patient privacy and security (HIPAA compliance).
Informed Consent: Patients must provide informed consent for telehealth services, including understanding the technology, privacy risks, and alternative care options.
Patient Records: Meticulous and secure record-keeping is required, just as with traditional in-person care.

Collaborative Practice and Supervision Requirements

Indiana's approach to collaborative practice and supervision significantly impacts the operational models of various healthcare entities, particularly those employing advanced practice providers:

Advanced Practice Registered Nurses (APRNs): Indiana law dictates the scope of practice for various APRN roles (Nurse Practitioners, Clinical Nurse Specialists, Certified Nurse Midwives, Certified Registered Nurse Anesthetists). While some roles historically required a collaborative practice agreement with a physician, Indiana has been progressing towards greater autonomy. For example, some APRN roles can prescribe certain legend drugs under a practice agreement, and the general trend is towards reducing the stringency of physician supervision for experienced APRNs. It is critical to consult the specific rules for each APRN specialty (e.g., 844 IAC 4-2) for current requirements.
Physician Assistants (PAs): PAs in Indiana practice under the supervision of a physician, as defined in Indiana Code 25-27.5-6. This supervision can be continuous but does not necessarily require the physical presence of the physician. The supervising physician is ultimately responsible for the PA's actions, and a written supervisory agreement or protocol must be in place. This includes specifying the scope of practice for the PA, delegation of duties, and methods of oversight.
Other Allied Health Professionals: For roles such as dental hygienists, physical therapists, or chiropractors, specific statutes and administrative codes outline their scope of practice, and any requirements for referral, supervision, or collaboration with other licensed professionals.

Any practice employing these professionals must ensure that their operational protocols, documentation, and agreements strictly align with the current Indiana statutes and administrative rules to avoid practicing outside the scope or inadequate supervision violations.

Controlled Substance Prescribing in Indiana: A Dual Federal and State Focus

Prescribing controlled substances in Indiana involves navigating both state-specific regulations and federal requirements, a landscape that has recently seen significant updates.

Indiana-Specific Requirements:

INSPECT (Indiana Scheduled Prescription Electronic Collection and Tracking): Indiana operates a robust Prescription Drug Monitoring Program (PDMP) known as INSPECT. All practitioners authorized to prescribe controlled substances are mandated to register with and utilize INSPECT prior to prescribing, dispensing, or administering Schedule II, III, IV, or V controlled substances. Regular checking of the patient's prescription history via INSPECT is a cornerstone of responsible prescribing in Indiana (IC 35-48-7-1 et seq.).
Quantity and Refill Limits: Indiana has specific rules regarding initial prescription quantities and refills for certain controlled substances, particularly opioids, to combat the opioid crisis. These often include limits on the duration of initial opioid prescriptions for acute pain.
Telehealth and Controlled Substances: While Indiana generally allows for telehealth prescribing, federal law, specifically the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, requires an initial in-person medical evaluation (or a limited set of exceptions) before prescribing controlled substances via telehealth. However, the DEA has historically provided temporary waivers during public health emergencies, and a new DEA final rule (discussed below) will shape the long-term landscape. Indiana prescribers must ensure their telehealth practices align with both state and federal requirements.

Integration of DEA Final Rule: The recent DEA Final Rule implementing key changes to Medication-Assisted Treatment (MAT) and Controlled Substance Prescribing (adopting provisions from the SUPPORT Act and Restoring Hope for Mental Health and Well-Being Act of 2022) is critical for all Indiana prescribers:

Elimination of DATA-Waiver: The "X-waiver" program for prescribing buprenorphine for Opioid Use Disorder (OUD) has been eliminated. This removes a significant administrative barrier, potentially increasing access to MAT in Indiana.
New Training Requirement: This is a crucial update. All practitioners registered with the DEA to prescribe controlled substances (Schedules II-V), including physicians, PAs, APRNs, dentists, and others in Indiana, must complete a new one-time, eight-hour training requirement on treating and managing patients with opioid or other substance use disorders. This training is now a prerequisite for obtaining or renewing a DEA registration. Practices must ensure all their prescribers are aware of and comply with this mandate immediately.
Pharmacy Delivery: The rule also codifies provisions allowing pharmacies to deliver certain controlled substances to a practitioner's registered location for maintenance or detoxification treatment, which can impact MAT administration logistics.

Non-compliance with INSPECT, state quantity limits, or the new federal DEA training requirements can lead to severe penalties, including license suspension, fines, and federal enforcement actions.

State-Specific Licensing and Registration Requirements

Expanding into Indiana necessitates a clear understanding of the various licensing and registration requirements overseen by the Indiana Professional Licensing Agency (PLA). This agency serves as the umbrella for over 40 professional boards, commissions, and committees.

Individual Professional Licenses: Each healthcare provider (physician, nurse, PA, chiropractor, dentist, therapist, etc.) must hold an active Indiana license pertinent to their profession. This involves application, educational verification, examination (if applicable), and background checks.
Business Entity Registration: Any corporate entity operating a healthcare practice must register with the Indiana Secretary of State. This includes filing articles of incorporation or organization and maintaining annual reports. For out-of-state entities, foreign entity registration is required.
Facility Licensing: While most individual practices are not facility-licensed in Indiana, certain types of facilities, such as ambulatory surgical centers, hospitals, or substance abuse treatment centers, are subject to specific licensing by the Indiana Department of Health (IDOH).
Controlled Substance Registrations: In addition to DEA registration, individual practitioners who prescribe controlled substances in Indiana typically need a state-issued controlled substance registration from the Indiana Board of Pharmacy.

Recent Enforcement Actions and Compliance Pitfalls

While specific recent Indiana-only enforcement cases directly mirroring the provided intelligence are not always broadly publicized, federal enforcement actions serve as potent reminders of universal compliance expectations, impacting Indiana practices just as profoundly.

Federal Healthcare Fraud: The sentencing of an Illinois chiropractor to federal prison for healthcare and related fraud serves as a stark warning to all healthcare providers, including those in Indiana, about the severe consequences of fraudulent billing, misrepresentation, and schemes designed to unlawfully enrich providers at the expense of insurance payers. This includes mail fraud, wire fraud, and direct healthcare fraud. Federal agencies like the Department of Justice actively pursue such cases, highlighting the critical need for robust compliance programs, meticulous record-keeping, and thorough staff training to ensure all billing and claims submission practices adhere to both federal and state regulations.
Kickbacks and Procurement Integrity: The plea of a former Intelligence Community contractor to federal kickback charges underscores the Department of Justice's broad focus on combating fraud and kickbacks across any program involving government funds. For Indiana healthcare entities participating in federal programs (e.g., Medicare, Medicaid) or contracting with government agencies, the principles of the Anti-Kickback Statute and the False Claims Act are directly applicable. Any arrangement that could be construed as influencing referrals or the procurement of services or goods through illegal inducements can lead to criminal charges and substantial financial penalties. Practices must ensure all business arrangements are transparent, commercially reasonable, and free from direct or indirect inducements.

Key Compliance Pitfalls in Indiana (and how to avoid them):

1. Inadequate CPOM Structuring: While Indiana is permissive, ignoring fee-splitting prohibitions or allowing corporate entities to dictate clinical care will lead to issues. Solution: Engage experienced healthcare counsel to review MSO agreements and corporate structures to ensure clear delineation of services and compliant financial arrangements. 2. Telehealth VPR Missteps: Assuming a VPR can always be established asynchronously for controlled substances, or failing to meet the standard of care via telehealth. Solution: Train providers on Indiana's specific VPR requirements and the nuances of federal controlled substance rules for telehealth. Implement robust technology and protocols for virtual examinations and patient intake. 3. Non-Compliance with INSPECT: Failure to register, use, or document review of the PDMP for controlled substance prescribing. Solution: Mandate and audit INSPECT use for all prescribers. Integrate INSPECT checks into clinical workflows and EMR systems. 4. Ignoring DEA Training Mandate: Failure to ensure all DEA-registered prescribers complete the new 8-hour controlled substance training. Solution: Proactively identify all DEA-registered staff, track their training completion, and update internal compliance policies to reflect this new requirement. 5. Improper Supervision Documentation: For PAs and APRNs, lacking a current, clearly defined, and properly executed supervisory or collaborative agreement. Solution: Regularly review and update all collaborative and supervisory agreements to align with current Indiana statutes and board rules. Ensure adequate documentation of oversight activities. 6. Billing Fraud: Any intentional or unintentional miscoding, upcoding, or billing for services not rendered. Solution: Implement rigorous internal auditing procedures, provide continuous training on billing and coding, and foster a culture of ethical billing.

What This Means For Your Practice in Indiana

Indiana offers a fertile ground for healthcare innovation and expansion, with its generally favorable CPOM landscape and progressive telehealth policies. However, this opportunity comes with a clear expectation of meticulous compliance with both state-specific regulations and overriding federal mandates. For telehealth founders, brick-and-mortar practice owners, compliance officers, and investors:

Due Diligence is Paramount: Before entering or expanding within Indiana, conduct comprehensive legal and compliance due diligence covering all aspects discussed here.
Invest in Robust Compliance Programs: Develop and implement strong compliance programs that include regular audits, staff training on state and federal regulations (including the new DEA training), and clear policies for telehealth, controlled substances, and billing.
Understand Collaborative Care Models: For practices utilizing APRNs and PAs, ensure all collaborative agreements and supervision protocols are meticulously crafted and regularly updated to reflect Indiana's dynamic legal landscape.
Stay Informed on Federal Updates: Changes from the DEA and DOJ can have immediate and direct impacts on Indiana operations. Continuous monitoring of federal regulatory intelligence is non-negotiable.
Leverage Expert Counsel: Partner with legal counsel experienced in Indiana healthcare law to structure your operations compliantly and navigate specific regulatory challenges.

Indiana's healthcare landscape offers significant potential, but realizing that potential hinges entirely on a proactive and informed approach to compliance. By understanding and meticulously adhering to these regulatory pillars, healthcare businesses can confidently build and scale their operations, ensuring both patient safety and long-term viability in the Hoosier State.